Insider Trading Activity Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – Director Sold 5,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Richard K Prins , Director of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) reportedly Sold 5,000 shares of the company’s stock at an average price of 14.8 for a total transaction amount of $74,000.00 SEC Form

Insider Trading History For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

On 8/15/2014 Floyd F Petersen, Director, bought 3,200 with an average share price of $10.35 per share and the total transaction amounting to $33,120.00.View SEC Filing

On 8/18/2014 Richard K Prins, Director, bought 4,000 with an average share price of $10.02 per share and the total transaction amounting to $40,080.00.View SEC Filing

On 8/19/2014 Michael A Zasloff, Director, bought 3,500 with an average share price of $10.00 per share and the total transaction amounting to $35,000.00.View SEC Filing

On 8/25/2014 Howard Lee, Director, bought 6,000 with an average share price of $10.84 per share and the total transaction amounting to $65,040.00.View SEC Filing

On 4/8/2015 Diane G Gerst, SVP, sold 10,000 with an average share price of $15.79 per share and the total transaction amounting to $157,900.00.View SEC Filing

On 4/9/2015 Marilyn J Purchase, VP, sold 28,000 with an average share price of $15.79 per share and the total transaction amounting to $442,120.00.View SEC Filing

On 5/19/2015 Richard K Prins, Director, sold 3,000 with an average share price of $14.94 per share and the total transaction amounting to $44,820.00.View SEC Filing

Analyst Ratings For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
These are 1 Hold Rating, 5 Buy Ratings .
The current consensus rating for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is Buy (Score: 2.83) with a consensus target price of $19.83 , a potential (33.20% upside)

Analyst Ratings History For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

On 3/14/2017 Needham & Company LLC Lower Price Target of rating Buy with a price target of $20.00 to $18.00
On 3/14/2017 Raymond James Financial, Inc. Downgraded rating Strong-Buy to Outperform with a price target of $21.00 to $18.00
On 7/22/2017 Wells Fargo & Company Reiterated Rating Buy
On 7/31/2017 BMO Capital Markets Reiterated Rating Hold with a price target of $16.00
On 8/9/2017 Piper Jaffray Companies Set Price Target of rating Buy with a price target of $19.00
On 8/11/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $20.00 to $19.00

Recent Trading Activity for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Shares of Amphastar Pharmaceuticals, Inc. closed the previous trading session at 14.89 up +0.09 0.61% with 119,418 shares trading hands.